HDL in atherosclerotic cardiovascular disease: in search of a role

M Casula, O Colpani, S Xie, AL Catapano, A Baragetti - Cells, 2021 - mdpi.com
For a long time, high-density lipoprotein cholesterol (HDL-C) has been regarded as a
cardiovascular disease (CVD) protective factor. Recently, several epidemiological studies …

[PDF][PDF] HDL in infectious diseases and sepsis

A Pirillo, AL Catapano, GD Norata - High density lipoproteins: from …, 2015 - library.oapen.org
During infection significant alterations in lipid metabolism and lipoprotein composition occur.
Triglyceride and VLDL cholesterol levels increase, while reduced HDL cholesterol (HDL-C) …

PCSK9 deficiency reduces insulin secretion and promotes glucose intolerance: the role of the low-density lipoprotein receptor

L Da Dalt, M Ruscica, F Bonacina… - European heart …, 2019 - academic.oup.com
Aims PCSK9 loss of function genetic variants are associated with lower low-density
lipoprotein cholesterol but also with higher plasma glucose levels and increased risk of Type …

High density lipoprotein cholesterol and the risk of all-cause mortality among US veterans

B Bowe, Y Xie, H Xian… - Clinical Journal of the …, 2016 - journals.lww.com
Results Patients with low HDL cholesterol and low eGFR had a higher burden of comorbid
illnesses. Over a median of 9.1 years (interquartile range, 7.7–9.4 years), 26,247 (40.1%) …

Myeloid apolipoprotein E controls dendritic cell antigen presentation and T cell activation

F Bonacina, D Coe, G Wang, MP Longhi… - Nature …, 2018 - nature.com
Cholesterol homeostasis has a pivotal function in regulating immune cells. Here we show
that apolipoprotein E (apoE) deficiency leads to the accumulation of cholesterol in the cell …

Obesity-induced metabolic stress leads to biased effector memory CD4+ T cell differentiation via PI3K p110δ-Akt-mediated signals

C Mauro, J Smith, D Cucchi, D Coe, H Fu, F Bonacina… - Cell metabolism, 2017 - cell.com
Low-grade systemic inflammation associated to obesity leads to cardiovascular
complications, caused partly by infiltration of adipose and vascular tissue by effector T cells …

Biology of proprotein convertase subtilisin kexin 9: beyond low-density lipoprotein cholesterol lowering

GD Norata, H Tavori, A Pirillo, S Fazio… - Cardiovascular …, 2016 - academic.oup.com
Proprotein convertase subtilisin kexin 9 (PCSK9) is a key regulator of low-density lipoprotein
receptor levels and LDL-cholesterol levels. Loss-of-function mutations in PCSK9 gene are …

[HTML][HTML] Low levels of high-density lipoprotein cholesterol increase the risk of incident kidney disease and its progression

B Bowe, Y Xie, H Xian, S Balasubramanian, Z Al-Aly - Kidney international, 2016 - Elsevier
Available experimental evidence suggests a role for high-density lipoprotein cholesterol
(HDL-C) in incident chronic kidney disease (CKD) and its progression. However, clinical …

Systemic and renal lipids in kidney disease development and progression

P Wahl, GM Ducasa, A Fornoni - American Journal of …, 2016 - journals.physiology.org
Altered lipid metabolism characterizes proteinuria and chronic kidney diseases. While it is
thought that dyslipidemia is a consequence of kidney disease, a large body of clinical and …

Biological consequences of dysfunctional HDL

A Pirillo, AL Catapano… - Current medicinal …, 2019 - ingentaconnect.com
Epidemiological studies have suggested an inverse correlation between high-density
lipoprotein (HDL) cholesterol levels and the risk of cardiovascular disease. HDLs promote …